• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - MAPLE GROVE TAXUS® LIBERTÉ®; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - MAPLE GROVE TAXUS® LIBERTÉ®; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number H7493893616400
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Abdominal Pain (1685); Death (1802); Edema (1820); High Blood Pressure/ Hypertension (1908); Myocardial Infarction (1969); Pain (1994)
Event Date 02/13/2013
Event Type  Death  
Event Description
Same case as mdr id# 2134265-2014-05184.(b)(4).It was reported that myocardial infarction (mi) and patient death occurred.In (b)(6) 2010, the patient presented due to elevated blood sugar, abdominal pain and altered mental status.The patient was diagnosed with unstable angina and cardiac catheterization was recommended.Subsequently, coronary angiography and index procedure were performed.Target lesion #1 was located in the mid right coronary artery (rca) with 85% stenosis and was 18 mm long with a reference vessel diameter of 3.50 mm.The lesion was treated with direct placement using a 24 x 3.50mm taxus® liberté® stent.Following post dilatation, residual stenosis was 0%.Target lesion #2 was located in the distal left circumflex (lcx) artery with 75% stenosis and was 12 mm long with a reference vessel diameter of 4.00 mm.The lesion was treated with direct placement using a 16 x 4.00mm taxus® liberté® stent.Following post-dilation with a non-bsc balloon, small perforation to the distal lcx artery was noted and was treated with placement of two non-bsc covered stents, resulting in 0% residual stenosis with sealing of perforation.Five days post procedure, the patient was discharged on aspirin and prasugrel.In (b)(6) 2013, the patient presented with complaints of abdominal pain, back pain and was noted to have elevated white blood cells (wbcs), non-healing wound, edema and weight gain.The patient was diagnosed with infected graft site and was hospitalized and treated with medications.At the time of the event, the patient was on aspirin and clopidogrel.The study drug per protocol was last taken in (b)(6) 2011.The event was considered resolved without residual effects and the patient was discharged on aspirin and clopidogrel the following day.Five days after hospitalization, the patient expired at 7:00 am due to acute mi.Autopsy was not performed.Per death certificate, the primary cause of death was acute mi and secondary causes were coronary artery disease, hypertension and diabetes.
 
Manufacturer Narrative
Device is a combination product.Device evaluated by mfr: the device was not returned for analysis.The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.The root cause is anticipated procedural complications as this event is a known physiological effect of the procedure and is noted within the dfu.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TAXUS® LIBERTÉ®
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC - MAPLE GROVE
one scimed place
maple grove MN 55311
Manufacturer Contact
ingrid matte
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key4058769
MDR Text Key4903107
Report Number2134265-2014-05185
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P060008
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 08/07/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/04/2014
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/22/2011
Device Model NumberH7493893616400
Device Catalogue Number38936-1640
Device Lot Number13367974
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/07/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/07/2010
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age56 YR
-
-